MarketInOut Stock Screener Log In | Sign Up
 

TransMedics Group Inc

NASDAQ • Healthcare • Medical Devices • Quote as of 05/13/2026 16:00
TransMedics Group Inc stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2,344.61 mln
Float33.44 mln
Earnings Date07/30/2026

EPS

4.37
Solid

P / E

14.69
Fair value

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-0.83
Highly suspicious

1-Year Forecast

118
Transformational upside

Relative Strength

1 / 100
Severely lagging

Business Description

TransMedics Group develops and sells technology that helps keep donor organs healthy outside the human body while they are being transported for transplant surgery. Their main product is the Organ Care System, a portable device that maintains near-natural conditions for donor hearts, lungs, and livers, giving doctors more time and flexibility during the transplant process. The company also runs a managed service that handles the full logistics of organ retrieval and delivery, including air and ground transportation. Founded in 1998 and based in Andover, Massachusetts, TransMedics operates across the United States and in other countries.

Key Fundamentals

EPS4.37
P/E14.69
ROE45.08
RPS16.14
ROIC17.26
ROA16.60
Interest Cover5.40
EBITDA, mln140
EV / EBITDA13.97
EV / EBIT18.28
Revenue, mln636
EV / Revenue3.07

Financial Strength

Altman Z-Score4.68
Piotroski F-Score 7 / 9
Beneish M-Score-0.83
Price to Graham Number1.83
1-Year Target Price118
Short Ratio7.77
Short % of Float34.35

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -11.99% 8 / 100   
1 Month -44.52% 2 / 100   
2 Months -50.77% 5 / 100   
6 Months -47.56% 11 / 100   
1 Year -45.94% 14 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us